EMEA (Europe, Middle East and Africa) Oral Vaccines Market Report 2017

Table of Contents

EMEA (Europe, Middle East and Africa) Oral Vaccines Market Report 2017
1 Oral Vaccines Overview
1.1 Product Overview and Scope of Oral Vaccines
1.2 Classification of Oral Vaccines
1.2.1 EMEA Oral Vaccines Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Oral Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Live Attenuated Vaccines
1.2.4 Killed/Inactivated Vaccines
1.2.5 Recombinant Vaccines
1.2.6 Others
1.3 EMEA Oral Vaccines Market by Application/End Users
1.3.1 EMEA Oral Vaccines Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Polio
1.3.3 Rabies
1.3.4 Rotavirus
1.3.5 Cholera
1.3.6 HIV
1.3.7 Respiratory Infections
1.3.8 Influenza
1.3.9 Tuberculosis
1.3.10 Others
1.4 EMEA Oral Vaccines Market by Region
1.4.1 EMEA Oral Vaccines Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Oral Vaccines (2012-2022)
1.5.1 EMEA Oral Vaccines Sales and Growth Rate (2012-2022)
1.5.2 EMEA Oral Vaccines Revenue and Growth Rate (2012-2022)

2 EMEA Oral Vaccines Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Oral Vaccines Market Competition by Players/Manufacturers
2.1.1 EMEA Oral Vaccines Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Oral Vaccines Revenue and Share by Players (2012-2017)
2.1.3 EMEA Oral Vaccines Sale Price by Players (2012-2017)
2.2 EMEA Oral Vaccines (Volume and Value) by Type/Product Category
2.2.1 EMEA Oral Vaccines Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Oral Vaccines Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Oral Vaccines Sale Price by Type (2012-2017)
2.3 EMEA Oral Vaccines (Volume) by Application
2.4 EMEA Oral Vaccines (Volume and Value) by Region
2.4.1 EMEA Oral Vaccines Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Oral Vaccines Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Oral Vaccines Sales Price by Region (2012-2017)

3 Europe Oral Vaccines (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Oral Vaccines Sales and Value (2012-2017)
3.1.1 Europe Oral Vaccines Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Oral Vaccines Revenue and Growth Rate (2012-2017)
3.2 Europe Oral Vaccines Sales and Market Share by Type
3.3 Europe Oral Vaccines Sales and Market Share by Application
3.4 Europe Oral Vaccines Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Oral Vaccines Sales Volume by Countries (2012-2017)
3.4.2 Europe Oral Vaccines Revenue by Countries (2012-2017)
3.4.3 Germany Oral Vaccines Sales and Growth Rate (2012-2017)
3.4.4 France Oral Vaccines Sales and Growth Rate (2012-2017)
3.4.5 UK Oral Vaccines Sales and Growth Rate (2012-2017)
3.4.6 Russia Oral Vaccines Sales and Growth Rate (2012-2017)
3.4.7 Italy Oral Vaccines Sales and Growth Rate (2012-2017)
3.4.8 Benelux Oral Vaccines Sales and Growth Rate (2012-2017)

4 Middle East Oral Vaccines (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Oral Vaccines Sales and Value (2012-2017)
4.1.1 Middle East Oral Vaccines Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Oral Vaccines Revenue and Growth Rate (2012-2017)
4.2 Middle East Oral Vaccines Sales and Market Share by Type
4.3 Middle East Oral Vaccines Sales and Market Share by Application
4.4 Middle East Oral Vaccines Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Oral Vaccines Sales Volume by Countries (2012-2017)
4.4.2 Middle East Oral Vaccines Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Oral Vaccines Sales and Growth Rate (2012-2017)
4.4.4 Israel Oral Vaccines Sales and Growth Rate (2012-2017)
4.4.5 UAE Oral Vaccines Sales and Growth Rate (2012-2017)
4.4.6 Iran Oral Vaccines Sales and Growth Rate (2012-2017)

5 Africa Oral Vaccines (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Oral Vaccines Sales and Value (2012-2017)
5.1.1 Africa Oral Vaccines Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Oral Vaccines Revenue and Growth Rate (2012-2017)
5.2 Africa Oral Vaccines Sales and Market Share by Type
5.3 Africa Oral Vaccines Sales and Market Share by Application
5.4 Africa Oral Vaccines Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Oral Vaccines Sales Volume by Countries (2012-2017)
5.4.2 Africa Oral Vaccines Revenue by Countries (2012-2017)
5.4.3 South Africa Oral Vaccines Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Oral Vaccines Sales and Growth Rate (2012-2017)
5.4.5 Egypt Oral Vaccines Sales and Growth Rate (2012-2017)
5.4.6 Algeria Oral Vaccines Sales and Growth Rate (2012-2017)

6 EMEA Oral Vaccines Manufacturers/Players Profiles and Sales Data
6.1 GlaxoSmithKline Plc.
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Oral Vaccines Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GlaxoSmithKline Plc. Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 PaxVax Corporation
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Oral Vaccines Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 PaxVax Corporation Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Pfizer Inc
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Oral Vaccines Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Pfizer Inc Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Merial, Inc.
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Oral Vaccines Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Merial, Inc. Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Merck Sharp & Dohme Corp
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Oral Vaccines Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Merck Sharp & Dohme Corp Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 VALNEVA Canada Inc.
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Oral Vaccines Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 VALNEVA Canada Inc. Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 QUíMICA SUIZA S.A
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Oral Vaccines Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 QUíMICA SUIZA S.A Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Immunitor, Inc
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Oral Vaccines Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Immunitor, Inc Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Aventis (Sanofi S.A.)
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Oral Vaccines Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Aventis (Sanofi S.A.) Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Serum Institute of India Pvt. Ltd
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Oral Vaccines Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Serum Institute of India Pvt. Ltd Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Swiss Serum and Vaccine Institute Berne
6.12 Bull Bio - NCIPD Ltd.
6.13 Vaxart, Inc.
6.14 Shantha Biotechnics
6.15 Crucell (Janssen Global Services, LLC)

7 Oral Vaccines Manufacturing Cost Analysis
7.1 Oral Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oral Vaccines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Oral Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oral Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Oral Vaccines Market Forecast (2017-2022)
11.1 EMEA Oral Vaccines Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Oral Vaccines Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Oral Vaccines Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Oral Vaccines Price and Trend Forecast (2017-2022)
11.2 EMEA Oral Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Oral Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Oral Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Oral Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Oral Vaccines Sales Forecast by Type (2017-2022)
11.7 EMEA Oral Vaccines Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Oral Vaccines
Figure EMEA Oral Vaccines Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Oral Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Live Attenuated Vaccines Product Picture
Figure Killed/Inactivated Vaccines Product Picture
Figure Recombinant Vaccines Product Picture
Figure Others Product Picture
Figure EMEA Oral Vaccines Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Oral Vaccines by Application in 2016
Figure Polio Examples
Table Key Downstream Customer in Polio
Figure Rabies Examples
Table Key Downstream Customer in Rabies
Figure Rotavirus Examples
Table Key Downstream Customer in Rotavirus
Figure Cholera Examples
Table Key Downstream Customer in Cholera
Figure HIV Examples
Table Key Downstream Customer in HIV
Figure Respiratory Infections Examples
Table Key Downstream Customer in Respiratory Infections
Figure Influenza Examples
Table Key Downstream Customer in Influenza
Figure Tuberculosis Examples
Table Key Downstream Customer in Tuberculosis
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Oral Vaccines Market Size (Million USD) by Region (2012-2022)
Figure Europe Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Oral Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Oral Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Africa Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Oral Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Oral Vaccines Sales Volume and Growth Rate (2012-2022)
Figure EMEA Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Oral Vaccines Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Oral Vaccines Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Oral Vaccines Sales Share by Players (2012-2017)
Figure 2016 Oral Vaccines Sales Share by Players
Figure 2017 Oral Vaccines Sales Share by Players
Figure EMEA Oral Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Oral Vaccines Revenue (Million USD) by Players (2012-2017)
Table EMEA Oral Vaccines Revenue Share by Players (2012-2017)
Table 2016 EMEA Oral Vaccines Revenue Share by Players
Table 2017 EMEA Oral Vaccines Revenue Share by Players
Table EMEA Oral Vaccines Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Oral Vaccines Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Oral Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of Oral Vaccines by Type (2012-2017)
Figure EMEA Oral Vaccines Sales Market Share by Type (2012-2017)
Table EMEA Oral Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Oral Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oral Vaccines by Type in 2016
Table EMEA Oral Vaccines Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Oral Vaccines Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Oral Vaccines Sales Share by Application (2012-2017)
Figure Sales Market Share of Oral Vaccines by Application (2012-2017)
Figure EMEA Oral Vaccines Sales Market Share by Application in 2016
Table EMEA Oral Vaccines Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Oral Vaccines Sales Share by Region (2012-2017)
Figure Sales Market Share of Oral Vaccines by Region (2012-2017)
Figure EMEA Oral Vaccines Sales Market Share in 2016
Table EMEA Oral Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Oral Vaccines Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Oral Vaccines by Region (2012-2017)
Figure EMEA Oral Vaccines Revenue Market Share Regions in 2016
Table EMEA Oral Vaccines Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Oral Vaccines Revenue and Growth Rate (2012-2017)
Table Europe Oral Vaccines Sales (K Units) by Type (2012-2017)
Table Europe Oral Vaccines Market Share by Type (2012-2017)
Figure Europe Oral Vaccines Market Share by Type in 2016
Table Europe Oral Vaccines Sales (K Units) by Application (2012-2017)
Table Europe Oral Vaccines Market Share by Application (2012-2017)
Figure Europe Oral Vaccines Market Share by Application in 2016
Table Europe Oral Vaccines Sales (K Units) by Countries (2012-2017)
Table Europe Oral Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe Oral Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe Oral Vaccines Sales Market Share by Countries in 2016
Table Europe Oral Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Europe Oral Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe Oral Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe Oral Vaccines Revenue Market Share by Countries in 2016
Figure Germany Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure France Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure UK Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Oral Vaccines Sales (K Units) by Type (2012-2017)
Table Middle East Oral Vaccines Market Share by Type (2012-2017)
Figure Middle East Oral Vaccines Market Share by Type (2012-2017)
Table Middle East Oral Vaccines Sales (K Units) by Applications (2012-2017)
Table Middle East Oral Vaccines Market Share by Applications (2012-2017)
Figure Middle East Oral Vaccines Sales Market Share by Application in 2016
Table Middle East Oral Vaccines Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Oral Vaccines Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Oral Vaccines Sales Volume Market Share by Countries in 2016
Table Middle East Oral Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Middle East Oral Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East Oral Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East Oral Vaccines Revenue Market Share by Countries in 2016
Figure Saudi Arabia Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Oral Vaccines Sales (K Units) by Type (2012-2017)
Table Africa Oral Vaccines Sales Market Share by Type (2012-2017)
Figure Africa Oral Vaccines Sales Market Share by Type (2012-2017)
Figure Africa Oral Vaccines Sales Market Share by Type in 2016
Table Africa Oral Vaccines Sales (K Units) by Application (2012-2017)
Table Africa Oral Vaccines Sales Market Share by Application (2012-2017)
Figure Africa Oral Vaccines Sales Market Share by Application (2012-2017)
Table Africa Oral Vaccines Sales Volume (K Units) by Countries (2012-2017)
Table Africa Oral Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa Oral Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa Oral Vaccines Sales Market Share by Countries in 2016
Table Africa Oral Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Africa Oral Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa Oral Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa Oral Vaccines Revenue Market Share by Countries in 2016
Figure South Africa Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Table GlaxoSmithKline Plc. Oral Vaccines Basic Information List
Table GlaxoSmithKline Plc. Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc. Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc. Oral Vaccines Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Plc. Oral Vaccines Revenue Market Share in EMEA (2012-2017)
Table PaxVax Corporation Oral Vaccines Basic Information List
Table PaxVax Corporation Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure PaxVax Corporation Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure PaxVax Corporation Oral Vaccines Sales Market Share in EMEA (2012-2017)
Figure PaxVax Corporation Oral Vaccines Revenue Market Share in EMEA (2012-2017)
Table Pfizer Inc Oral Vaccines Basic Information List
Table Pfizer Inc Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Inc Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Inc Oral Vaccines Sales Market Share in EMEA (2012-2017)
Figure Pfizer Inc Oral Vaccines Revenue Market Share in EMEA (2012-2017)
Table Merial, Inc. Oral Vaccines Basic Information List
Table Merial, Inc. Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merial, Inc. Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Merial, Inc. Oral Vaccines Sales Market Share in EMEA (2012-2017)
Figure Merial, Inc. Oral Vaccines Revenue Market Share in EMEA (2012-2017)
Table Merck Sharp & Dohme Corp Oral Vaccines Basic Information List
Table Merck Sharp & Dohme Corp Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Sharp & Dohme Corp Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Sharp & Dohme Corp Oral Vaccines Sales Market Share in EMEA (2012-2017)
Figure Merck Sharp & Dohme Corp Oral Vaccines Revenue Market Share in EMEA (2012-2017)
Table VALNEVA Canada Inc. Oral Vaccines Basic Information List
Table VALNEVA Canada Inc. Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure VALNEVA Canada Inc. Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure VALNEVA Canada Inc. Oral Vaccines Sales Market Share in EMEA (2012-2017)
Figure VALNEVA Canada Inc. Oral Vaccines Revenue Market Share in EMEA (2012-2017)
Table QUíMICA SUIZA S.A Oral Vaccines Basic Information List
Table QUíMICA SUIZA S.A Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure QUíMICA SUIZA S.A Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure QUíMICA SUIZA S.A Oral Vaccines Sales Market Share in EMEA (2012-2017)
Figure QUíMICA SUIZA S.A Oral Vaccines Revenue Market Share in EMEA (2012-2017)
Table Immunitor, Inc Oral Vaccines Basic Information List
Table Immunitor, Inc Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Immunitor, Inc Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Immunitor, Inc Oral Vaccines Sales Market Share in EMEA (2012-2017)
Figure Immunitor, Inc Oral Vaccines Revenue Market Share in EMEA (2012-2017)
Table Aventis (Sanofi S.A.) Oral Vaccines Basic Information List
Table Aventis (Sanofi S.A.) Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aventis (Sanofi S.A.) Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Aventis (Sanofi S.A.) Oral Vaccines Sales Market Share in EMEA (2012-2017)
Figure Aventis (Sanofi S.A.) Oral Vaccines Revenue Market Share in EMEA (2012-2017)
Table Serum Institute of India Pvt. Ltd Oral Vaccines Basic Information List
Table Serum Institute of India Pvt. Ltd Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Serum Institute of India Pvt. Ltd Oral Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Serum Institute of India Pvt. Ltd Oral Vaccines Sales Market Share in EMEA (2012-2017)
Figure Serum Institute of India Pvt. Ltd Oral Vaccines Revenue Market Share in EMEA (2012-2017)
Table Swiss Serum and Vaccine Institute Berne Oral Vaccines Basic Information List
Table Bull Bio - NCIPD Ltd. Oral Vaccines Basic Information List
Table Vaxart, Inc. Oral Vaccines Basic Information List
Table Shantha Biotechnics Oral Vaccines Basic Information List
Table Crucell (Janssen Global Services, LLC) Oral Vaccines Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Vaccines
Figure Manufacturing Process Analysis of Oral Vaccines
Figure Oral Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Oral Vaccines Major Manufacturers in 2016
Table Major Buyers of Oral Vaccines
Table Distributors/Traders List
Figure EMEA Oral Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Oral Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Oral Vaccines Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Oral Vaccines Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Oral Vaccines Sales Market Share Forecast by Region (2017-2022)
Table EMEA Oral Vaccines Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Oral Vaccines Revenue Market Share Forecast by Region (2017-2022)
Table Europe Oral Vaccines Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Oral Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Europe Oral Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Oral Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Oral Vaccines Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Oral Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Oral Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Oral Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Oral Vaccines Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Oral Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Africa Oral Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Oral Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Oral Vaccines Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Oral Vaccines Sales Market Share Forecast by Type (2017-2022)
Table EMEA Oral Vaccines Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Oral Vaccines Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.